These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2311130)
1. Kinetic studies of the hydrolysis of platinum-DNA complexes by nuclease S1. Butour JL; Mazard AM; Vieussens C; Johnson NP Chem Biol Interact; 1990; 73(2-3):195-205. PubMed ID: 2311130 [TBL] [Abstract][Full Text] [Related]
2. Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation. Bernges F; Dörner G; Holler E Eur J Biochem; 1990 Aug; 191(3):743-53. PubMed ID: 2167853 [TBL] [Abstract][Full Text] [Related]
3. Combination of S1 nuclease and PNA for site-selective hydrolysis of double-stranded DNA. Comparison with the site-selective hydrolysis using Ce(IV)/EDTA. Yamamoto Y; Komiyama M Nucleic Acids Symp Ser (Oxf); 2004; (48):149-50. PubMed ID: 17150522 [TBL] [Abstract][Full Text] [Related]
4. Sequence selective double strand DNA cleavage by peptide nucleic acid (PNA) targeting using nuclease S1. Demidov V; Frank-Kamenetskii MD; Egholm M; Buchardt O; Nielsen PE Nucleic Acids Res; 1993 May; 21(9):2103-7. PubMed ID: 8502550 [TBL] [Abstract][Full Text] [Related]
5. Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution. Foka M; Paoletti J Biochem Pharmacol; 1986 Oct; 35(19):3283-91. PubMed ID: 3768022 [TBL] [Abstract][Full Text] [Related]
6. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]. Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659 [TBL] [Abstract][Full Text] [Related]
7. Parameters influencing the flow cytometric analysis of DNA sensitivity to nuclease S1. Prosperi E; Giangaré MC; Supino R; Bottiroli G Histochemistry; 1990; 93(4):417-21. PubMed ID: 2323956 [TBL] [Abstract][Full Text] [Related]
8. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin. Hongo A; Seki S; Akiyama K; Kudo T Int J Biochem; 1994 Aug; 26(8):1009-16. PubMed ID: 8088411 [TBL] [Abstract][Full Text] [Related]
9. Partial P1 nuclease digestion as a probe of tRNA structure. Aultman KS; Chang SH Eur J Biochem; 1982 Jun; 124(3):471-6. PubMed ID: 6286304 [TBL] [Abstract][Full Text] [Related]
10. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2]. Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105 [TBL] [Abstract][Full Text] [Related]
11. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Roberts JJ; Friedlos F Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217 [TBL] [Abstract][Full Text] [Related]
12. Interaction of quercetin with DNA. Alvi NK; Rizvi RY; Hadi SM Biosci Rep; 1986 Oct; 6(10):861-8. PubMed ID: 3030459 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of the conformation of RNA from phage MS2 and 16S rRNA. Accessibility to nucleases S1 and SV specific to secondary structure and thermal stability]. Grechko VV; Borisova OF; Sakharova NK; Timokhina GI; Kuznetsova NV Mol Biol (Mosk); 1987; 21(2):506-14. PubMed ID: 2439895 [TBL] [Abstract][Full Text] [Related]
14. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Mello JA; Lippard SJ; Essigmann JM Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087 [TBL] [Abstract][Full Text] [Related]
15. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
16. Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies. Sundquist WI; Lippard SJ; Stollar BD Biochemistry; 1986 Apr; 25(7):1520-4. PubMed ID: 3707890 [TBL] [Abstract][Full Text] [Related]
17. Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues. Lönn U; Lönn S Mol Pharmacol; 1987 Jul; 32(1):154-61. PubMed ID: 3037300 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). Sundquist WI; Lippard SJ; Stollar BD Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320 [TBL] [Abstract][Full Text] [Related]
19. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA. Yaneva J; Leuba SH; van Holde K; Zlatanova J Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045 [TBL] [Abstract][Full Text] [Related]
20. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication. Heiger-Bernays WJ; Essigmann JM; Lippard SJ Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]